The purpose of this study was to evaluate trabecular bone response, at fifty-two week follow-up, to four different synthetic graft materials (CaSO4 and CaSO4 – HA/TCP composites) as compared to autograft in a canine defect model. The group with the highest HA/ TCP proportion had the greatest amount of residual graft material and total mineralized material. Increasing the proportion of HA/TCP reduces the rate of dissolution, and appears to have little effect on bone formation at long term follow-up. This study further suggests that a range of composites could be created to match the spectrum of resorption rates demanded by clinical applications.

The purpose of this study was to evaluate trabecular bone response to four synthetic graft materials (CaSO4 and CaSO4 – HA/TCP composites) as compared to autograft in a canine defect model, at long term follow-up.

Both 85% CaSO4 – 15% HA/TCP and 65% CaSO4 – 15% HA/TCP showed bone formation similar to autograft. The group with the highest proportion of HA/TCP lasted longer than the other formulations. The results suggest that increased HA/TCP proportions reduce the rates of dissolution, without compromising bone formation in the current model.

Results suggests that a range of composites could be created to match the spectrum of resorption rates demanded by clinical applications.

In this REB-approved RCT, bilateral humeral and femoral cylindrical defects were filled with one of four types of pellets with varying proportions of CaSO4 – HA/TCP, autograft bone, or left unfilled. After sacrifice at six, twelve, twenty-six or fifty-two weeks, defect sites were evaluated histologically for tissue and inflammatory response, area fractions of residual graft material, and bone ingrowth in the defects.

The area of the defect occupied by residual graft material in the group with the highest percentage of HA/TCP was greater than in other composite groups (p< 0.0001). This group contained the greatest amount of total mineralized material (graft material + bone) (p< 0.03. The extent of new bone formation increased from twelve to twenty-six weeks (p< 0.0001). Both 85% CaSO4 – 15% HA/TCP and 65% CaSO4 – 15% HA/TCP showed bone formation similar to autograft.

Funding: Research grant from Stryker Howmedica, Matwah, NJ.

The purpose of this study was to evaluate trabecular bone response to four different synthetic graft materials (CaSO₄ and CaSO₄ – HA/TCP composites) as compared to autograft in a canine defect model. The group with the highest HA/TCP proportion (and the lowest CaSO4 proportion) had the greatest amount of residual graft material and total mineralized material (p< 0.05). Increasing the proportion of HA/TCP reduces the rate of dissolution, and appears to have little effect on bone formation. This study suggests that a range of composites could be created to match the spectrum of resorption rates demanded by clinical applications.

Calcium sulfates and phosphates have become popular clinically for use as bone graft substitutes, however, their in-vivo performance has not been well characterized. The purpose of this study was to evaluate trabecular bone response to four synthetic graft materials (CaSO₄ and CaSO₄ – HA/TCP composites) as compared to autograft in a canine defect model.

Both 100% CaSO₄ and the 3 CaSO₄– HA/TCP formulations showed good bone formation. The group with the highest proportion of HA/TCP lasted longer than the other formulations, suggesting increased HA/TCP proportions reduce the rates of dissolution, without compromising bone formation in the current model.

Results suggests that a range of composites could be created to match the spectrum of resorption rates demanded by clinical applications.

In this REB-approved RCT, bilateral humeral and femoral cylindrical defects were filled with one of four types of pellets with varying proportions of CaSO₄ – HA/TCP, autograft bone, or left unfilled. After sacrifice at six or twelve weeks, defect sites were evaluated histologically for tissue and inflammatory response, area fractions of residual graft material, and bone ingrowth in the defects.

The area of the defect occupied by residual graft material in the group with the highest percentage of HA/TCP was greater than in other composite groups (p< 0.0006). At twelve weeks, this group contained more total mineralized material (graft material + bone) (p< 0.005). The extent of new bone formation was not different among the composite groups at either time-point, but all showed more bone formation than the empty defect.

Funding: This study was funded by a research grant from Stryker Howmedica, Matwah, NJ.

Introduction and Aims: Titanium foam implants simulate the trabecular structure of bone to maximise porous space for bone ingrowth. Plasma-sprayed hydroxyapatite coatings work well on non-porous substrates but do not coat the inner surfaces of open-porous substrates. Chemical deposition is an attractive alternative that produces consistent coats on porous surfaces.

Method: Titanium foam cylinders (5mm diameter by 25mm length) were implanted bilaterally in 40 rabbit femurs. Twenty implants were coated with 20 microns of hydroxyapatite (T-HA) by electrochemical deposition while 20 implants had no hydroxyapatite coat (T). Osseointegration was measured at six and 12 weeks by automated computerised histomorphometry of scanning electron microscopy images of sections taken through the implant at two levels: diaphyseal and metaphyseal. Bone ingrowth was quantified in the pores and was also measured up to 1mm beyond the surface of the implant to determine the pattern of bone growth.

Results: For the T-HA surface, bone ingrowth increased from 35.0 ±8.5 % at six weeks to 41.5 ± 7.4 % at 12 weeks (p < 0.05). For the T surface, bone growth was 14.1 ± 8.8% at six weeks and 11.4 ± 4.2 % at 12 weeks. At both time points mean bone ingrowth was significantly different between hydroxyapatite-coated and non-hydroxyapatite-coated implants, (p< 0.01). No significant differences were noted between the diaphyseal and metaphyseal bone response.

Conclusion: For the T-HA surface, bone ingrowth increased from 35.0 ±8.5 % at six weeks to 41.5 ± 7.4 % at 12 weeks (p < 0.05). For the T surface, bone growth was 14.1 ± 8.8% at six weeks and 11.4 ± 4.2 % at 12 weeks. At both time points mean bone ingrowth was significantly different between hydroxyapatite-coated and non-hydroxyapatite-coated implants, (p< 0.01). No significant differences were noted between the diaphyseal and metaphyseal bone response.

Introduction and Aims: Calcium sulfates and phosphates have become popular as bone graft substitutes, however, their in-vivo performance has not been well characterised. The purpose of this study was to evaluate trabecular bone response to four synthetic graft materials (CaSO4 and CaSO4 – HA/TCP composites) as compared to autograft in a canine defect model.

Method: In this REB-approved RCT, bilateral humeral and femoral cylindrical defects were filled with one of four types of pellets with varying proportions of CaSO4 – HA/TCP, autograft bone, or left unfilled. After sacrifice at six or 12 weeks, defect sites were evaluated histologically for tissue and inflammatory response, area fractions of residual graft material, and bone ingrowth in the defects.

Results: The area of the defect occupied by residual graft material in the group with the highest percentage of HA/TCP was greater than in other composite groups (p< 0.0006). At 12 weeks, this group contained more total mineralised material (graft material + bone) (p< 0.005). The extent of new bone formation was not different among the composite groups at either time-point, but all showed more bone formation than the empty defect. Both 100% CaSO4 and the 3 CaSO4 – HA/TCP formulations showed good bone formation.

Conclusion: The group with the highest proportion of HA/TCP lasted longest, suggesting increased HA/TCP proportions reduce the rates of dissolution, without compromising bone formation in this model. Results suggest that a range of composites could be created to match the spectrum of resorption rates demanded by clinical applications.